Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000437417 | SCV000520787 | likely benign | not provided | 2018-10-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003522967 | SCV004284485 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2024-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022343 | SCV004863516 | likely benign | Cardiovascular phenotype | 2021-08-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001700370 | SCV001925743 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000437417 | SCV001954072 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000437417 | SCV001974116 | likely benign | not provided | no assertion criteria provided | clinical testing |